Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Thrombocytopenia D013921 15 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Thromboangiitis Obliterans D013919 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Tachycardia, Paroxysmal D013614 2 associated lipids
Tachycardia D013610 7 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Strongyle Infections, Equine D013319 1 associated lipids
Streptococcal Infections D013290 4 associated lipids
Stomach Volvulus D013277 1 associated lipids
Stomach Ulcer D013276 75 associated lipids
Gastric Dilatation D013271 1 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Sneezing D012912 6 associated lipids
Shock, Septic D012772 11 associated lipids
Shock D012769 11 associated lipids
Seizures D012640 87 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Schorer AE Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody. 1997 Thromb. Res. pmid:9062953
van der Weiden RM et al. Prostanoid excretion in incipient singleton and twin pregnancies. 1996 Am. J. Obstet. Gynecol. pmid:9065139
Teng CM et al. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. 1997 Thromb. Haemost. pmid:9066010
Tanabe K et al. Erythrocyte magnesium and prostaglandin dynamics in chronic sleep deprivation. 1997 Clin Cardiol pmid:9068914
Held HD et al. Phosphodiesterase inhibitors prevent endothelin-1-induced vasoconstriction, bronchoconstriction, and thromboxane release in perfused rat lung. 1997 Biochem. Biophys. Res. Commun. pmid:9070212
Fitzpatrick FA et al. A radioimmunoassay for thromboxane B2. 1977 Anal. Biochem. pmid:907115
Gomi T et al. Protective effect of thromboxane synthetase inhibitor on hypertensive renal damage in Dahl salt-sensitive rats. 1995 Clin Exp Pharmacol Physiol Suppl pmid:9072433
Zheng NX et al. Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model. 1996 Oct-Dec Eur J Drug Metab Pharmacokinet pmid:9074892
Bröijersén A et al. No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9081681
Mori TA et al. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9081682
Hsieh YZ and Kuo KL Analysis of prostaglandins by micellar electrokinetic capillary chromatography. 1997 J Chromatogr A pmid:9084156
Stichtenoth DO et al. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. 1997 J. Investig. Med. pmid:9084574
Güllner HG et al. Prostacyclin overproduction in Bartter's syndrome. 1979 Lancet pmid:90861
Davis TM et al. Prostacyclin and thromboxane metabolites in diabetes. 1979 Lancet pmid:90875
Yamamoto S et al. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. 1997 Am. J. Physiol. pmid:9087598
Best L et al. Effect of glucose on platelet thromboxane biosynthesis. 1979 Lancet pmid:90876
Kulkarni P and Payne S Eicosanoids in bovine retinal microcirculation. 1997 J Ocul Pharmacol Ther pmid:9090614
Kume S [Evaluation and problems on platelet function tests]. 1997 Nippon Rinsho pmid:9097565
Rocha FA et al. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats. 1997 J Lipid Mediat Cell Signal pmid:9101418
Shellhaas CS et al. Intravillous eicosanoid compartmentalization and regulation of placental blood flow. 1997 Mar-Apr J. Soc. Gynecol. Investig. pmid:9101462
Cueto SM et al. beta-Carotene attenuates peroxide-induced vasoconstriction in the human placenta. 1997 Mar-Apr J. Soc. Gynecol. Investig. pmid:9101463
Yasui K et al. Involvement of thromboxane A2 in antigen-induced nasal blockage in guinea pigs. 1997 Int. Arch. Allergy Immunol. pmid:9104797
Tomas-Barberan S et al. Effect of diclofenac on prostaglandin liberation in the rabbit after photorefractive keratectomy. 1997 Mar-Apr J Refract Surg pmid:9109071
Zeltsman D et al. Pathophysiologic plasma levels of leukotriene C4 in relation to the hemodynamic dysfunction and mediator release of graded bacteremia. 1997 Shock pmid:9110414
Barry MC et al. Immunological and physiological responses to aortic surgery: effect of reperfusion on neutrophil and monocyte activation and pulmonary function. 1997 Br J Surg pmid:9112905
Brus F et al. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity. 1997 Pediatrics pmid:9113943
Hayball PJ et al. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. 1993 Br J Clin Pharmacol pmid:9114902
Mitra A et al. Thromboxane-mediated alveolar responses to acute obstruction of the pulmonary vasculature. 1997 Am. J. Respir. Crit. Care Med. pmid:9117035
Cambridge H et al. Plasma thromboxane B2 levels in horses experimentally infected with Strongylus vulgaris. 1989 Equine Vet J Suppl pmid:9118097
Murota SI et al. The effects of thromboxane B2 and 6-ketoprostaglandin F1alpha on cultured fibroblasts. 1977 Biochim. Biophys. Acta pmid:911847
Aibiki M and Cook JA Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. 1997 Crit. Care Med. pmid:9118658
Shinohara M et al. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation]. 1997 Rinsho Byori pmid:9121003
Teraoka S et al. Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9122990
Ishine N et al. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123045
Suehiro T et al. Value of caval effluent in predicting early graft function after orthotopic liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123086
Yagi T et al. Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. 1997 Feb-Mar Transplant. Proc. pmid:9123352
Cheng Z et al. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats. 1997 Vet. Rec. pmid:9123796
He CF et al. Postural vasoregulation and mediators of reperfusion injury in venous ulceration. 1997 J. Vasc. Surg. pmid:9129619
Oelkers R et al. Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. 1997 Br J Clin Pharmacol pmid:9131946
Olson KR et al. Cardiovascular effects of homologous bradykinin in rainbow trout. 1997 Am. J. Physiol. pmid:9140009
Todd MK et al. Comparison of methods for evaluating exercise-induced changes in thromboxane B2 and beta-thromboglobulin. 1997 Med Sci Sports Exerc pmid:9140910
Henrion D et al. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. 1997 Br. J. Pharmacol. pmid:9146891
Riendeau D et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. 1997 Br. J. Pharmacol. pmid:9146894
Bishop-Bailey D et al. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. 1997 Br. J. Pharmacol. pmid:9146896
Roberts LJ et al. Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite. 1977 J. Biol. Chem. pmid:914816
Kraft M et al. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. 1997 Chest pmid:9149578
Zhang T et al. Effects of the incubation of long-chain polyunsaturated fatty acids on platelet lipids and thromboxane release. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9150370
Sinzinger H et al. PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion technique. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9150379
Closa D et al. Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9150380
Shimada Y et al. Role of platelets in myocardial ischemia-reperfusion injury in dogs. 1997 Jpn. Circ. J. pmid:9152773